The Hatch-Waxman Act A Quarter Century Later

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service. Resources, Science, and Industry Division

Language:

English

Subjects (All):

Medical laws and legislation.

Patents.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[United States] [publisher not identified] 2012

Summary:

Provides overview of P.L. 98-417, the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products to accelerate generic drug approval process. Summarizes amendments made to Hatch-Waxman by the Medicare Prescription Drug and Modernization Act of 2003. Reviews implementation; and selected issues related to authorized generics, patent settlements, and follow-on biologics

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Jan. 2013). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Resources, Science, and Industry Division. Hatch-Waxman Act

Publisher Number:

CRS-2011-RSI-0151

Access Restriction:

Restricted for use by site license